newsfilter
← Latest News
GlobeNewswire·

Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SANTA MONICA, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant" or "Company") (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced the Compensation